GEN Exclusives

More »

GEN Poll

More »
Feb 26, 2014

Greg Lucier: Life after Life Tech

In a single decade, Greg Lucier, 49, transformed the relatively small firm Invitrogen into the international behemoth Life Technologies. Now that Thermo Fisher Scientific has completed its acquisition of Life Tech, Lucier says he may try “to serve in some appointed or possibly even elected capacity.” (For more on Greg Lucier, click here.) Would you vote for Lucier?

Would you vote for former Life Technologies CEO Greg Lucier if he ran for public office?


Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Tackling the Global Problem of Fake Medicines

Policy proposals to address the growing global problem of fake medicines include a global agreement, similar to the Framework Convention on Tobacco Control, and stricter national laws to prosecute those who knowingly sell counterfeit medicines. Do you think these steps will be successful?

More »